Abstract
With the aging of the haemophilia population, age related comorbidities become more and more a medical issue. Managing haemophilia patients with cardiovascular disease is a difficult task for many haemophilia-treating physicians. Over the years, insights on prevalence, risk factors and management of cardiovascular disease in haemophilia have improved substantially. It is now recognised that many risk factors, such as hypertension and overweight, occur quite frequently in patients with haemophilia. Several new insights in anticoagulation management of atrial fibrillation and coronary ischaemia in haemophilia have been suggested. This review provides an general overview of the current knowledge of these topics in literature.
| Original language | English |
|---|---|
| Pages (from-to) | 196-201 |
| Number of pages | 6 |
| Journal | Hämostaseologie |
| Volume | 37 |
| Issue number | 3 |
| Early online date | 14 Dec 2016 |
| DOIs | |
| Publication status | Published - 7 Aug 2017 |
Keywords
- Anticoagulation
- Cardiovascular
- Haemophilia
- Age Factors
- Cross-Sectional Studies
- Comorbidity
- Factor IX/metabolism
- Humans
- Middle Aged
- Risk Factors
- Hemophilia A/blood
- Anticoagulants/adverse effects
- Atrial Fibrillation/blood
- Cardiovascular Diseases/blood
- Factor VIII/metabolism
- Myocardial Infarction/blood
- Aged, 80 and over
- Aged
- Coronary Artery Disease/blood
- anticoagulation
- cardiovascular
- haemophilia
Fingerprint
Dive into the research topics of 'Management of cardiovascular disease in aging persons with haemophilia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver